Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
11/22/2007 | US20070269429 Treatment with anti-erbb2 antibodies |
11/22/2007 | US20070269403 Composition and method for treatment of hepatic encephalopathy |
11/22/2007 | CA2652500A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
11/22/2007 | CA2652499A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
11/22/2007 | CA2652333A1 Pharmaceutical composition for treating or preventing hcv infection |
11/22/2007 | CA2652041A1 Food compositions and methods of treating periodontal disease |
11/22/2007 | CA2652023A1 New form of administration of racecadotril |
11/22/2007 | CA2651883A1 Method and means for treating inflammatory bowel disease |
11/21/2007 | EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
11/21/2007 | EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
11/21/2007 | EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
11/21/2007 | EP1857546A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
11/21/2007 | EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same |
11/21/2007 | EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them |
11/21/2007 | EP1857110A2 Hormone replacement therapy |
11/21/2007 | EP1857105A2 Cathartic composition |
11/21/2007 | EP1856153A1 Ykl-40 monoclonal antibodies |
11/21/2007 | EP1856146A2 Fgf growth factor analogs |
11/21/2007 | EP1856110A1 Oxyindole derivatives as 5ht4 receptor agonists |
11/21/2007 | EP1856067A1 Crystal forms of 2-(3-fluoro4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
11/21/2007 | EP1856041A1 Crystallisation and purification of glycopyrronium bromide |
11/21/2007 | EP1855681A1 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject |
11/21/2007 | EP1855680A2 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
11/21/2007 | EP1855550A2 Nutritional composition with probiotics |
11/21/2007 | EP1505964B1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
11/21/2007 | EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists |
11/21/2007 | EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
11/21/2007 | EP1350112B1 Methods for the treatment of ibs |
11/21/2007 | EP1315485B1 Cathartic composition |
11/21/2007 | EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
11/21/2007 | EP1269196B1 Method of screening for inhibitors of osteopontin |
11/21/2007 | EP1188445B1 Drug composition containing lecithin-modified superoxide dismutase |
11/21/2007 | EP0981374B1 Sustained-release delayed gels |
11/21/2007 | EP0842196B1 Cell adhesion inhibitors |
11/21/2007 | CN101076542A Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof |
11/21/2007 | CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor |
11/21/2007 | CN101076350A Compositions for hcv treatment |
11/21/2007 | CN101076346A Lactic acid bacteria and its application in preventing diarrhea |
11/21/2007 | CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol |
11/21/2007 | CN101074415A Acanthopanax-root wine and its production |
11/21/2007 | CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues |
11/21/2007 | CN101074210A Pharmaceutically active isoindoline derivatives |
11/21/2007 | CN101074202A Production of injecting reductive glutathione |
11/21/2007 | CN101073685A Medicinal-magnetic seat cushion and back cushion |
11/21/2007 | CN101073660A Chinese-medicinal composition for treating chronic hepatitis B and its production |
11/21/2007 | CN101073657A 'Yu Chuang Dan' Chinese-medicinal preparation for treating recurrent oral exulceratio |
11/21/2007 | CN101073648A Method for treating senile constipation |
11/21/2007 | CN101073645A Body-building oral liquid |
11/21/2007 | CN101073617A Use of medicinal composition in treatment of micro-circulation handicap and prevention of stroke |
11/21/2007 | CN101073609A Fuming cirrus for treating hepatitis B, its production and use |
11/21/2007 | CN101073605A Bistort Rhizome effective component and its use |
11/21/2007 | CN101073602A Medicinal composition for treating or improving liver function, its production and use |
11/21/2007 | CN101073601A Chinese medicine for treating acute enteronitis and its disperse tablet |
11/21/2007 | CN101073595A Glycyrrhiza total flavonoid and total saponin extract and its production |
11/21/2007 | CN101073593A Compound bi-dismutation agent and its production |
11/21/2007 | CN101073590A Muxiang total lactone extract and its production |
11/21/2007 | CN101073585A Microbial preparation for improving eel liver growth and its making method |
11/21/2007 | CN101073576A Aldoforwe ester self-emulsifying capsule preparation and its making method |
11/21/2007 | CN101073427A Glossy ganoderma cordycepin beverage and its production |
11/21/2007 | CN101073407A Edible refreshing pearl and its production |
11/21/2007 | CN101073358A Intestines-nourishing tea |
11/21/2007 | CN101073356A Stomach-invigorating and bowel-relaxing tea |
11/21/2007 | CN101073351A Memory-enhancing tea with brain-invigorating and vision-improving functions |
11/21/2007 | CN101073350A White Chinese herbaceous peony tea with bowel-relaxing function |
11/21/2007 | CN101073340A Rose beauty sour milk |
11/21/2007 | CN101073333A Multi-flavor biscuit |
11/21/2007 | CN101073330A Appetizing Baxian cake |
11/21/2007 | CN100349922C Nanometer mushroom amylose and preparation method of its injection |
11/21/2007 | CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
11/21/2007 | CN100349613C Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
11/21/2007 | CN100349610C Oral adhering piece for treating oral exulceratio, and its prepn. method |
11/21/2007 | CN100349609C Cirrhosis treating medicine |
11/21/2007 | CN100349607C Extraction and purification of Chinese medicine for treating ulcer colonitis and clinical research |
11/21/2007 | CN100349599C Swim bladder marrow growing capsule |
11/21/2007 | CN100349595C Medicinal composition for catharsis |
11/21/2007 | CN100349587C Medicine for treating acute and chronic pancreatitis |
11/21/2007 | CN100349580C Mould catching agent and medicinal/health caring use |
11/21/2007 | CN100349578C Medicine composition for treating atrophic gastritis |
11/21/2007 | CN100349574C Drugs for periodontal diseases |
11/21/2007 | CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
11/21/2007 | CN100349524C Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
11/20/2007 | US7297818 Adamantane derivatives |
11/20/2007 | US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
11/20/2007 | US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration |
11/20/2007 | US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
11/20/2007 | US7297682 liquid crystal diphosphate polymorph; antibacterial and antiprotozoal agents |
11/20/2007 | US7297523 Human elongase genes and uses thereof |
11/20/2007 | US7297346 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain attention deficit hyperactivity disorder and fatigue |
11/20/2007 | US7297332 Protease, a gene therefor and the use thereof |
11/15/2007 | WO2007130823A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
11/15/2007 | WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
11/15/2007 | WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. |
11/15/2007 | WO2007129961A1 Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation |
11/15/2007 | WO2007129743A1 Anti-inflammatory composition |
11/15/2007 | WO2007129725A1 Agent for preventing liver disease |
11/15/2007 | WO2007129701A1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake |
11/15/2007 | WO2007129473A1 Bicyclic aryl derivative |
11/15/2007 | WO2007129428A1 Method for isolation of stem cell |
11/15/2007 | WO2007129040A1 p38 MAP KINASE INHIBITORS |
11/15/2007 | WO2007128462A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms |